Abstract
A one-year-and-seven-months-old boy was hospitalised because of fever, cough and general malaise. A diagnosed tonsillitis and pneumonia were treated with intravenous antibiotics. His clinical condition worsened despite antibiotic therapy. After immunologic investigations revealed both a cellular and a humoral immune disorder, a broncho-alveolar lavage was performed. The culture revealed Legionella pneumophila. Antibiotic treatment was then changed to erythromycin in combination with rifampicin, with a good response. Although rarely described in childhood, one should consider L. pneumophila as a possible pathogen in immunocompromised children presenting with pneumonia.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
Antibiotics, Antitubercular / therapeutic use
-
Bronchoalveolar Lavage Fluid / microbiology
-
Drug Therapy, Combination / therapeutic use
-
Erythromycin / therapeutic use
-
Fluoroquinolones
-
Humans
-
Immunocompromised Host*
-
Infant
-
Legionella pneumophila / isolation & purification
-
Legionnaires' Disease / diagnosis*
-
Legionnaires' Disease / drug therapy
-
Male
-
Pneumonia, Bacterial / diagnosis*
-
Pneumonia, Bacterial / drug therapy
-
Rifampin / therapeutic use
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Antibiotics, Antitubercular
-
Fluoroquinolones
-
Erythromycin
-
Rifampin